Skip to content

Effect of Combined Therapy on Adults with Tension-Type Headaches and Balance Problems

Efficacy of Integrative Therapy Combining Vestibular Rehabilitation, Vagus Nerve Stimulation, and Craniofacial Release for Tension-Type Headache with Coexisting Vestibular Dysfunction: A Randomized Controlled Trial - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094547
Enrollment
135
Registered
2025-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M279- Disease of jaws, unspecified

Interventions

Intervention1: Integrative Neuromusculoskeletal Therapy (INMT): Integrative Neuromusculoskeletal Therapy (INMT) combines three synergistic components aimed at addressing both the neurological and musc

Sponsors

Dr Ramesh Chandra Patra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants eligible for inclusion in the study were adults aged between 18 and 65 years with a clinical diagnosis of chronic tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. In addition, participants were required to have coexisting vestibular dysfunction, confirmed by clinical assessment and a Dizziness Handicap Inventory (DHI) score greater than 30. All participants were required to provide written informed consent and express willingness to comply with the study protocol.

Exclusion criteria

Exclusion criteria: Participants were excluded if they had secondary headache disorders, a history of epilepsy, severe psychiatric illness, or the presence of a cardiac pacemaker. Pregnant or lactating women were also excluded due to unknown effects of the interventions on fetal and neonatal health. Individuals with recent head trauma within the past six months or those currently enrolled in other clinical trials were not eligible to participate, to avoid confounding factors and ensure the safety and scientific validity of the study results.

Design outcomes

Primary

MeasureTime frame
Change in number of headache days per month from baseline to 12 weeksTimepoint: Change in number of headache days per month from baseline to 12 weeks

Secondary

MeasureTime frame
Change in headache intensity (VAS scale, 0?10) Change in DHI score Change in SF-36 quality of life scores Pericranial muscle tenderness scores (standardized scale)Timepoint: Baseline, Week 6, Week 12

Countries

India

Contacts

Public ContactDr Ramesh Chandra Patra

Lovely Professional University Faculty of Applied Medical Sciences

ramesh.19500@lpu.co.in09653174563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026